EDUCATION
2000 – Postdoc, University of Maryland School of Medicine; Wadsworth Center, New York State Department of Health;
1999 – Ph.D., Chinese Academy of Sciences
Dr. Xie received the Ph.D. in Genetics from Institute of Genetics and Developmental Biology, Chinese Academy of Sciences. During Ph.D. studies, Dr. Xie discovered a strong promoter for bioengineering from viral genome which was awarded a USA patent. During his postdoctoral training, Dr. Xie discovered novel diagnostic and prognostic markers of prostate cancer such as PIM-1L and nMET. Dr. Xie also found mechanisms of multiple drug resistance, novel signaling networks in prostate, breast cancer and leukemia. Dr. Xie has been invited as speaker in a number of international conferences in USA and China. Dr. Xie has supervised students to carry out cancer research and to publish their research results since he joined the Nazarbayev University as an Assistant Professor in 2015. Dr. Xie’s current research is focusing on molecular and biochemical mechanisms of cancer progression and precision cancer therapeutics.
